RxDoctor Payments Data

Karyn-Anne Cumberbatch, MD

Obstetrics & Gynecology · Missouri City, TXNPI 1073618344

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $447,184 of the $451,934 with a category attached, or 98.9%. 5 manufacturers reported payments, led by CSL Plasma Inc. at 57.7% of the total. Among obstetrics & gynecology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$451,934in general payments, 2019–2025

Across 579 payments — averaging $780.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Plasma Inc.$261K
  • CSL Behring$188K
  • Eli Lilly$3K
  • Duchesnay USA Incorporated$121
  • Lupin Inc.$17
$869,700in research payments, 2019–2025

Across 54 payments — averaging $16,106 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Evofem Biosciences, Inc.$577K
  • Merck$293K

What the payments were for

  • Royalty or licence$5250%
  • Consulting fees$447,18499%
  • Travel & lodging$4,0871%
  • Food & beverage$1380%

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
CSL Plasma Inc.374$260,707
CSL Behring201$187,800
Eli Lilly2$3,288
Duchesnay USA Incorporated1$121
Lupin Inc.1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$451,934 in reported general payments places this provider in the 95th percentile of 3,099 obstetrics & gynecology providers in Texas.

See all obstetrics & gynecology providers in Texas

Medicare billing

Part B allowed, 2024
$70,544
Medicare patients
218
Services billed
1,194

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other obstetrics & gynecology in Missouri City

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →